News

Shattuck Labs to Showcase Innovations at December Investor Events

Shattuck Labs to Showcase Innovations at December Investor Events

Introduction to Shattuck Labs, Inc.

Shattuck Labs, Inc. (NASDAQ: STTK) is a leading biotechnology firm dedicated to developing innovative therapeutics. They focus on addressing unmet medical needs in treating cancer and chronic immune-related diseases.

Participation in Upcoming Investor Conferences

In an exciting move, Shattuck Labs has announced its participation in two significant investor conferences happening this December. As a company at the forefront of biotech research, these conferences provide an excellent platform for Shattuck to connect with investors and share insights into its current projects.

Piper Sandler 36th Annual Healthcare Conference

One of the highlights is the participation in the Piper Sandler 36th Annual Healthcare Conference. Here, Dr. Taylor Schreiber, Shattuck's Chief Executive Officer, will deliver a corporate presentation. This event is scheduled for December 3 and will take place at 12:30 p.m. ET. This is a valuable opportunity for attendees to learn more about the company's strategic direction and innovative therapies.

Evercore 7th Annual HealthCONx Conference

Following that, on December 4, Dr. Schreiber will engage in a fireside chat at the Evercore 7th Annual HealthCONx Conference. This format allows for an informal and engaging discussion around the company’s mission and achievements while providing insights into the fascinating fields of immunology and oncology. The conversation is set for 8:45 a.m. ET, and it promises to touch on pivotal developments in their therapeutic landscape.

Live Webcast Availability

For those unable to attend in person, Shattuck Labs will also provide a live webcast of both events. This webcast will be accessible via the Investors section of their website, ensuring that even those who cannot attend can stay informed about the company’s latest developments. A replay will be made available for up to 90 days post-event, allowing further access to the valuable content shared.

About Shattuck Labs' Research Focus

Shattuck Labs specializes in transformative treatments for autoimmune/inflammatory diseases and cancer through advanced protein engineering. Their lead program, SL-325, represents a groundbreaking approach in targeting TNF superfamily receptors, with the goal of offering first-in-class antibodies aimed at conditions like inflammatory bowel disease (IBD) and other autoimmune disorders.

By utilizing novel TNF receptor agonist and antagonist therapeutics, Shattuck Labs aims to carve out new strategies in the fight against complex diseases. The company's innovative approach highlights its commitment to improving patient outcomes and enhancing the quality of life for those suffering from challenging health conditions.

Company Location and Mission

With operational hubs in Austin, Texas, and Durham, North Carolina, Shattuck Labs is perfectly positioned to foster collaboration and innovation within the biotech ecosystem. Their aim to push the boundaries of treatment possibilities positions them as a vital player in the industry.

Contact Information

For more inquiries regarding investor relations, contact Conor Richardson, the Vice President of Investor Relations at Shattuck Labs, via email at InvestorRelations@shattucklabs.com. Engaging with their investor relations team will provide further insights into Shattuck's future plans and investment opportunities.

Frequently Asked Questions

What is Shattuck Labs known for?

Shattuck Labs is recognized for developing novel therapeutics targeted at cancer and chronic immune-related diseases.

Who will be speaking at the investor conferences?

Dr. Taylor Schreiber, the CEO of Shattuck Labs, will be the presenter at both conferences.

How can I watch the events if I can't attend in person?

The events will be available via live webcast on Shattuck Labs' Investor section of the website.

What is the significance of the SL-325 program?

SL-325 aims to provide a first-in-class treatment for autoimmune diseases, representing a major step forward in therapeutic options.

What is the mission of Shattuck Labs?

Shattuck Labs' mission is to innovate and improve treatment alternatives for patients suffering from complex conditions like cancer and autoimmune diseases.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 70

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 119

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 155

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 146

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading
Texxon Faces Revenue Slide Amid Strategic Shifts

Updated Category News Views 108

Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...

Continue Reading
Québecor Makes Its Move: Eye on TELUS Amid Telecom Shakeup

Updated Category News Views 142

The Offer That Shocked the Telecom Markets Just when you think you’ve figured out the lay of the land, someone throws a curveball. Québecor’s decision to take a run at TELUS is shaking up Canada’s telecom scene big time. This isn’t just another M&A whisper; it’s a roaring freight train of a proposal valued at a whopping $31 billion. And TELUS, not just sitting...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 163

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 88

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 100

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
NVCA Refreshes Key Venture Legal Documents for 2026

Updated Category News Views 115

Keeping Pace with Evolving Venture Norms Change never lets up in the fast-paced world of venture capital, does it? Just when you think you've got the rules figured out, the game shifts. This time, it's the National Venture Capital Association (NVCA) shaking things up. They've given a facelift to seven of their model legal documents, a move that reshapes the legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Lake Chelan Health Partners with Medline for Improved Care

Updated Category News Views 364

Lake Chelan Health's Collaboration with Medline In an exciting development, Lake Chelan Health, a critical access hospital located in Washington, has entered into a strategic Prime Vendor agreement with Medline, one of the leading suppliers of medical-surgical products. This partnership is set to elevate their supply chain resilience and enhance the availability of...

Continue Reading
Investors of Dow Inc. Urged to Join Class Action Lawsuit

Updated Category News Views 232

Invitation for Dow Inc. Investors Are you an investor in Dow Inc. (DOW)? If you have faced significant losses during a certain period, there is an opportunity for you to become involved in a class action lawsuit. This is especially important for those who acquired Dow securities from January 30, 2025 to July 23, 2025. Individuals who believe they are eligible are...

Continue Reading
Strategic Growth at Future Technologies with New Chairperson

Updated Category News Views 197

Future Technologies Ventures Welcomes New Leadership In a strategic move to enhance its operations, Future Technologies Venture, LLC recently appointed Mary Peterson as Chairperson of its Advisory Board. This significant addition comes after a recapitalization with Battle Investment Group, marking an exciting chapter for the company. Mary Peterson's Role in Future...

Continue Reading
Cineverse Brings Halloween Thrills with 31-Day SCREAMBOX Event

Updated Category News Views 180

Cineverse's 31 Days of Halloween Celebration Cineverse is gearing up for an exciting Halloween season with their unique event, 31 Days of Halloween, hosted on their SCREAMBOX streaming service. This initiative aims to deliver chilling thrills and engaging experiences tailored for horror enthusiasts around the globe. Featured Film Premiere: Bloodsuckers and the Grimoire...

Continue Reading
ParkerVision Prevails Against Qualcomm in U.S. Federal Court

Updated Category News Views 77

ParkerVision Achieves a Legal Milestone Against Qualcomm The legal battle between ParkerVision and Qualcomm has taken a notable turn, with ParkerVision recently securing a significant victory. The U.S. Court of Appeals for the Federal Circuit has delivered a favorable opinion, marking an important moment for ParkerVision as it strives to safeguard its intellectual...

Continue Reading